Abbott Laboratories (NYSE:ABT) to Hold Q3 2008 Earnings Conference Call October 15

Abbott Laboratories (NYSE:ABT) will hold a conference call on Wednesday, October 15 at 9:00 am ET to discuss the third quarter earnings for 2008.  The call will be lead by EVP, Finance and CFO Thomas Freyman and VP, Investor Relations John Thomas.  Interested parties may hear the call via webcast by visiting abbottinvestor.com.

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a diversified line of healthcare products. It has four segments. The Pharmaceutical Products segment’s products include adult and pediatric pharmaceuticals. The Diagnostic Products segment’s products include diagnostic systems and tests for blood banks, hospitals, commercial laboratories, physicians’ offices, alternate care testing sites, plasma protein therapeutic companies and consumers. The Nutritional Products segment’s products include a line of pediatric and adult nutritional. The Vascular Products segment’s products include a line of coronary, endovascular and vessel closure devices.

In February 2008, the United States Food and Drug Administration (FDA) approved the Company's SIMCOR (Niaspan/simvastatin), a medicine for cholesterol management. In January 2008, Abbott’s HUMIRA (adalimumab) received approval from FDA, for moderate to severe chronic plaque psoriasis.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.

The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.

Create your profile on The Global Market Directory